Save Article

GlaxoSmithKline Considers
Christopher Gent as Director

By

David PringleStaff Reporter of The Wall Street Journal

Updated May 17, 2004 12:01 a.m. ET

LONDON -- GlaxoSmithKline PLC, the pharmaceuticals company, is considering appointing Sir Christopher Gent, the former chief executive of Vodafone Group PLC, as a nonexecutive director, according to a person familiar with the situation.

The United Kingdom newspaper the Sunday Telegraph reported yesterday that Sir Christopher is expected to take up a nonexecutive position with GlaxoSmithKline, based in Brentford, England, as a precursor to becoming chairman of the company when Sir Christopher Hogg, the current chairman, retires.